Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?
Cássio Morais Loss, Lucas Teodoro, Gabriela Doná Rodrigues, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 22

Showing 22 citing articles:

Review: Cannabinoids as Medicinals
Jag H. Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 36
Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy
Victor Voicu, Felix-Mircea Brehar, Corneliu Toader, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1388-1388
Open Access | Times Cited: 26
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment
Tibor Štark, Serena Di Martino, Filippo Drago, et al.
Pharmacological Research (2021) Vol. 174, pp. 105938-105938
Closed Access | Times Cited: 31
Autism and associated disorders: cannabis as a potential therapy
Mariana Babayeva, Haregewein Assefa, Paramita Basu, et al.
Frontiers in Bioscience-Elite (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia
Tibor Štark, Fabio Arturo Iannotti, Serena Di Martino, et al.
Biomolecules (2022) Vol. 12, Iss. 1, pp. 108-108
Open Access | Times Cited: 12
El papel de los cannabinoides en los trastornos del neurodesarrollo de niños y adolescentes
Francisca Freitas, Sofia Pimenta, Sara Soares, et al.
Revista de Neurología (2022) Vol. 75, Iss. 07, pp. 189-189
Open Access | Times Cited: 8
Clinical Data on Canabinoids: Translational Research in the Treatment of Autism Spectrum Disorders
Laura D. Carreira, Francisca C. Matias, María G. Campos
Biomedicines (2022) Vol. 10, Iss. 4, pp. 796-796
Open Access | Times Cited: 7
The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders
Roberto Coccurello, Maria Cristina Marrone, Mauro Maccarrone
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Pengaruh Pemberian Neurodevelopmental Treatment, Play Therapy, dan Neuro Senso Terhadap Peningkatan Motorik Kasar Pada Anak Down syndrome
Wulan Adis Aranti, Arif Pristianto
Physiotherapy & Health Science (PhysioHS) (2023) Vol. 5, Iss. 1, pp. 18-25
Open Access | Times Cited: 3
THC improves behavioural schizophrenia-like deficits that CBD fails to overcome: a comprehensive multilevel approach using the Poly I:C maternal immune activation
Nicolás Lamanna‐Rama, Diego Romero‐Miguel, Marta Casquero‐Veiga, et al.
Psychiatry Research (2023) Vol. 331, pp. 115643-115643
Closed Access | Times Cited: 3
Pathophysiology of the endocannabinoid system in Autism Spectrum Disorder: A Narrative Review
Andrey Alves Siqueira de Miranda, Carla Caroline Vieira e Silva, Marcus Vinícius de Alencar Barbosa, et al.
International Journal of Health Science (2024) Vol. 4, Iss. 19, pp. 2-11
Open Access
THE USE OF CANNABIDIOL IN PEDIATRIC DENTISTRY PATIENTS WITH AUTISM SPECTRUM DISORDER: INTEGRATIVE REVIEW
Anna Bertoldi, Walter Bertoldi Neto, Andres Camilo Campo Arevalo, et al.
Brazilian Journal of Implantology and Health Sciences (2024) Vol. 6, Iss. 6, pp. 1120-1134
Open Access
Cannabis Compounds: Potential Therapy for Neurological Disease
Mariana Babayeva, Zvi G. Loewy
IntechOpen eBooks (2024)
Open Access
Efeitos do nitroprussiato de sódio e do canabidiol no modelo animal de psicose por cetamina S+ e cetamina R em ratos machos e fêmeas
Isabella Caroline da Silva Dias
(2024)
Open Access
OS BENEFÍCIOS DO CANABIDIOL NO TRATAMENTO EM CRIANÇAS COM TRANSTORNOS NEURODIVERGENTES
Suelen Cerdeira Bentes Albuquerque, Larissa Aguiar de Mendonça
Revista Contemporânea (2024) Vol. 4, Iss. 10, pp. e6384-e6384
Open Access
Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice
João Francisco Cordeiro Pedrazzi, Amanda J. Sales, Rafaela Ponciano, et al.
Pharmacology Biochemistry and Behavior (2024), pp. 173919-173919
Closed Access
Effects of Cannabidiol Isolated or in Association With Risperidone in an Animal Model of Autism
Maiara de Aguiar da Costa, Gustavo Fernandes, Eduarda Maiochi, et al.
Developmental Neurobiology (2024) Vol. 85, Iss. 1
Closed Access
The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
Gabriela Visini, Samara Brown, Katrina Weston–Green, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 2

Stefano Marini, Lucia D’Agostino, Marika Mentana, et al.
International Journal of Clinical Studies and Medical Case Reports (2023) Vol. 30, Iss. 1
Open Access
Avaliação dos efeitos do canabidiol sobre as consequências comportamentais induzidas pelo tratamento com o ácido valproico durante o período embrionário do zebrafish
Karla Cristinne Mancini Costa
(2023)
Open Access
Cannabidiol: Overview, Complexities, and Opportunities for Behavioral Health
Susan R.B. Weiss, Katia Delrahim Howlett
Psychiatry update (2022), pp. 27-42
Closed Access
Treatment of schizophrenia and bipolar disorder (ChAD) - a review of the literature
Jakub Klas, Natalia Kluz, Mikołaj Makaryczew, et al.
Journal of Education Health and Sport (2021) Vol. 11, Iss. 9, pp. 473-483
Open Access
Page 1

Scroll to top